Agomelatine

Agomelatine Research Standard

Agomelatine is a synthetic melatonergic agent and a structural analogue of melatonin. In laboratory research, it is classified as an atypical psychotropic reference standard, functioning as a selective agonist at melatonin MT1 and MT2 receptors and a selective antagonist at 5-HT2C serotonin receptors. It is widely utilized in neuroscience research to investigate circadian rhythm resynchronization, neurogenesis, and the molecular mechanisms underlying mood-related neuropharmacology in experimental models.

Technical Specifications

Mechanism of Action & Research Context

Agomelatine’s research utility is defined by its unique dual-action profile, distinct from conventional monoamine-based agents.

• Melatonergic Agonism: Agomelatine binds with high affinity to MT1 and MT2 melatonin receptors, mimicking the signaling of endogenous melatonin. This is used in experimental models to probe the resynchronization of circadian rhythms and the modulation of sleep-wake cycle disturbances.

• 5-HT2C Antagonism: By acting as a selective antagonist at 5-HT2C receptors, the compound disinhibits the release of norepinephrine and dopamine, particularly within the frontal cortex. Researchers utilize this mechanism to study the synergistic interplay between melatonergic signaling and monoaminergic release in neuroplasticity models.

• Neuroprotective Signaling: Investigations focus on the compound’s ability to promote hippocampal neurogenesis, upregulate BDNF expression, and improve neuronal plasticity, providing a probe for studying resilience in neurodegenerative or stress-response paradigms.

Research Applications

Agomelatine is a specialized reagent essential for comparative pharmacological and circadian biology research.

Primary fields of in vitro and laboratory investigation include:

• Circadian Biology: Mapping the effects of MT1/MT2 receptor modulation on the central clock and peripheral oscillator function.

• Neurogenesis Studies: Analyzing the role of 5-HT2C antagonism in hippocampal proliferation, maturation, and survival of neurons.

• Comparative Pharmacodynamics: Benchmarking agomelatine against standard SSRIs or melatonin receptor ligands to delineate differences in monoaminergic signaling and synaptic plasticity.

• Signaling Pathway Analysis: Utilizing agomelatine to elucidate the cross-talk between melatonin and serotonin receptor pathways in corticolimbic structures.

Storage & Handling Guidelines

To maintain the chemical stability and experimental reliability of the compound:

• Storage Environment: Store in a cool, dry place. Maintain at -20°C for long-term stability.

• Environmental Control: Protect strictly from light and moisture. The molecule is stable under standard storage, but light exposure can lead to degradation of the naphthalene core.

• Handling: Allow the container to equilibrate to room temperature before opening to minimize condensation. Utilize standard laboratory safety practices and appropriate PPE.

• Aseptic Technique: Ensure the use of sterile laboratory tools to prevent cross-contamination during preparation of solutions for in vitro experiments.

Research Use Disclaimer

Research Use Only Disclaimer: This product is developed and distributed strictly as a Research Use Only (RUO) laboratory reference chemical intended exclusively for non-clinical analytical and scientific investigation. It is not an FDA-approved drug, medical treatment, dietary supplement, or food ingredient, and is strictly prohibited for human or animal consumption. Kimera Chems supplies this high-purity research material solely to qualified institutions and professional investigators for authorized laboratory research.